Ahmad Mourad

Ahmad Mourad

Duke University

H-index: 13

North America-United States

About Ahmad Mourad

Ahmad Mourad, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at Duke University, specializes in the field of Infectious Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Time to Sustained Recovery between Oral Tablet and Inhaler Placebos in the ACTIV-6 Platform Clinical Trial

Which trial do we need? Percutaneous mechanical aspiration versus medical management alone for treatment of right-sided valvular infective endocarditis

Who Benefits? An Assessment of Resident Benefits at Top 50 Academic Institutions

Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial

Disparities in Mpox vaccination among priority populations during the 2022 outbreak

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Scoping review of percutaneous mechanical aspiration for valvular and cardiac implantable electronic device infective endocarditis

Concurrent Sexually Transmitted Infection Testing Among Patients Tested for Mpox at a Tertiary Healthcare System

Ahmad Mourad Information

University

Position

Medical Center

Citations(all)

986

Citations(since 2020)

956

Cited By

176

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

13

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Ahmad Mourad Skills & Research Interests

Infectious Diseases

Top articles of Ahmad Mourad

Time to Sustained Recovery between Oral Tablet and Inhaler Placebos in the ACTIV-6 Platform Clinical Trial

Journal of Clinical and Translational Science

2024/4

Yue Gao
Yue Gao

H-Index: 1

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Which trial do we need? Percutaneous mechanical aspiration versus medical management alone for treatment of right-sided valvular infective endocarditis

Clinical Microbiology and Infection

2024/2/8

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Nicholas A Turner
Nicholas A Turner

H-Index: 9

Who Benefits? An Assessment of Resident Benefits at Top 50 Academic Institutions

Journal of Surgical Education

2024/3/1

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Marcelo Cerullo
Marcelo Cerullo

H-Index: 11

Disparities in Mpox vaccination among priority populations during the 2022 outbreak

Open Forum Infectious Diseases

2023/9

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine

2023/9/1

Scoping review of percutaneous mechanical aspiration for valvular and cardiac implantable electronic device infective endocarditis

2023/8/25

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Nicholas A Turner
Nicholas A Turner

H-Index: 9

Concurrent Sexually Transmitted Infection Testing Among Patients Tested for Mpox at a Tertiary Healthcare System

Open Forum Infectious Diseases

2023/8

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Dexamethasone for Inpatients With COVID-19 in a National Cohort

JAMA Network Open

2023/4/3

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Siyun Yang
Siyun Yang

H-Index: 11

Which trial do we need? Next Generation Sequencing to Individualize Therapy in Staphylococcus aureus Bacteremia

Clinical Microbiology and Infection

2023/4/9

Ahmad Mourad
Ahmad Mourad

H-Index: 7

The association of baseline plasma SARS-CoV-2 nucleocapsid antigen level and outcomes in patients hospitalized with COVID-19

Annals of internal medicine

2022/10

Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

Med

2022/8/12

Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?

Antimicrobial Agents and Chemotherapy

2022/6/21

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Nicholas A Turner
Nicholas A Turner

H-Index: 9

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised …

The Lancet Infectious Diseases

2022/5/1

Mycoplasma pneumoniae-associated diffuse alveolar haemorrhage: an atypical presentation of a prevalent pathogen

BMJ Case Reports

2022/4

Ahmad Mourad
Ahmad Mourad

H-Index: 7

COVID-19 Trials: Who Participates and Who Benefits?

Southern medical journal

2022/4

Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data

2020

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Nicholas A Turner
Nicholas A Turner

H-Index: 9

Reduction in Expected Survival Associated with Nontuberculous Mycobacterial Pulmonary Disease

Clinical Infectious Diseases

2021/5/15

Ahmad Mourad
Ahmad Mourad

H-Index: 7

See List of Professors in Ahmad Mourad University(Duke University)